Login

Financial Snapshot

Revenue
TTM
$337.0B
Gross Margin
TTM
63.49%
Net Income
TTM
$41.96B
Current Assets
2026 Q1
$301.8B
Current Liabilities
2026 Q1
$167.5B
Current Ratio
2026 Q1
180.2%
Total Assets
2026 Q1
$581.2B
Total Liabilities
2026 Q1
$202.3B
Book Value
2026 Q1
378.9B
Cash
2026 Q1
$15.37B
P/E
TTM
25.34
Free Cash Flow
TTM
$18.33B

Stock Price

Loading...
Market Cap: $1.0633 Trillion

About Dr Reddy's Laboratories Ltd

Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. The company is headquartered in Hyderabad, Telangana and currently employs 26,944 full-time employees. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC) pharmaceutical products. The company works in the areas of gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its segments consist of Global Generics; Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment consists of the Company's business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). The Pharmaceutical Services and Active Ingredients segment consists of the Company's business of manufacturing and marketing APIs and intermediates.

Industry: Pharmaceutical Preparations

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support